Yield10 Bioscience, Inc. (NASDAQ:YTEN – Get Rating) – Research analysts at HC Wainwright issued their Q1 2023 earnings per share (EPS) estimates for Yield10 Bioscience in a report issued on Wednesday, March 15th. HC Wainwright analyst A. Dayal anticipates that the specialty chemicals company will post earnings of ($0.45) per share for the quarter. HC Wainwright also issued estimates for Yield10 Bioscience’s Q2 2023 earnings at ($0.50) EPS, Q3 2023 earnings at ($0.33) EPS, Q4 2023 earnings at ($0.36) EPS and FY2027 earnings at $0.12 EPS.
Yield10 Bioscience Trading Up 11.7 %
Shares of Yield10 Bioscience stock opened at $2.58 on Thursday. The stock has a market capitalization of $12.80 million, a price-to-earnings ratio of -0.96 and a beta of 1.75. Yield10 Bioscience has a twelve month low of $1.63 and a twelve month high of $6.12. The business’s 50 day simple moving average is $3.18 and its 200-day simple moving average is $2.82.
Hedge Funds Weigh In On Yield10 Bioscience
About Yield10 Bioscience
Yield10 Bioscience, Inc operates as an agricultural bioscience company. It focuses on the development of technologies to produce step-change improvements in crop yield for food and feed crops to enhance global food security. The company was founded by Anthony J. Sinskey, Simon F. Williams and Oliver P.
Read More
- Get a free copy of the StockNews.com research report on Yield10 Bioscience (YTEN)
- Don’t Miss Out: $2 Trillion Could be Headed to the Banking Sector
- A Weakening Economy Suggests Caution Before Buying Five Below
- Williams-Sonoma: Time To Buy At Rock-Bottom PricesĀ
- Why DraftKings Could Keep Outperforming in 2023
- Charles Schwab And The Safest 30% You Can Make This Year
Receive News & Ratings for Yield10 Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yield10 Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.